These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 17477865

  • 1. Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré.
    Bonnet M, Roper C, Félix M, Coulibaly L, Kankolongo GM, Guthmann JP.
    Malar J; 2007 May 03; 6():54. PubMed ID: 17477865
    [Abstract] [Full Text] [Related]

  • 2. Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
    Swarthout TD, van den Broek IV, Kayembe G, Montgomery J, Pota H, Roper C.
    Trop Med Int Health; 2006 Oct 03; 11(10):1503-11. PubMed ID: 17002724
    [Abstract] [Full Text] [Related]

  • 3. Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural Tanzania.
    Eriksen J, Mwankusye S, Mduma S, Veiga MI, Kitua A, Tomson G, Petzold MG, Swedberg G, Gustafsson LL, Warsame M.
    Trans R Soc Trop Med Hyg; 2008 Feb 03; 102(2):137-42. PubMed ID: 18082233
    [Abstract] [Full Text] [Related]

  • 4. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
    Happi CT, Gbotosho GO, Folarin OA, Akinboye DO, Yusuf BO, Ebong OO, Sowunmi A, Kyle DE, Milhous W, Wirth DF, Oduola AM.
    Acta Trop; 2005 Sep 03; 95(3):183-93. PubMed ID: 16023986
    [Abstract] [Full Text] [Related]

  • 5. Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria.
    Dorsey G, Vlahos J, Kamya MR, Staedke SG, Rosenthal PJ.
    J Infect Dis; 2003 Oct 15; 188(8):1231-8. PubMed ID: 14551894
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of combination therapy with artesunate plus amodiaquine compared to monotherapy with chloroquine, amodiaquine or sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum in Afghanistan.
    Durrani N, Leslie T, Rahim S, Graham K, Ahmad F, Rowland M.
    Trop Med Int Health; 2005 Jun 15; 10(6):521-9. PubMed ID: 15941414
    [Abstract] [Full Text] [Related]

  • 7. Adding artesunate to sulphadoxine-pyrimethamine greatly improves the treatment efficacy in children with uncomplicated falciparum malaria on the coast of Benin, West Africa.
    Nahum A, Erhart A, Gazard D, Agbowai C, Van Overmeir C, van Loen H, Menten J, Akogbeto M, Coosemans M, Massougbodji A, D'Alessandro U.
    Malar J; 2007 Dec 21; 6():170. PubMed ID: 18154655
    [Abstract] [Full Text] [Related]

  • 8. Epidemiology of drug-resistant malaria in Republic of Congo: using molecular evidence for monitoring antimalarial drug resistance combined with assessment of antimalarial drug use.
    Nsimba B, Jafari-Guemouri S, Malonga DA, Mouata AM, Kiori J, Louya F, Yocka D, Malanda M, Durand R, Le Bras J.
    Trop Med Int Health; 2005 Oct 21; 10(10):1030-7. PubMed ID: 16185238
    [Abstract] [Full Text] [Related]

  • 9. Malaria in the Nuba Mountains of Sudan: baseline genotypic resistance and efficacy of the artesunate plus sulfadoxine-pyrimethamine and artesunate plus amodiaquine combinations.
    Hamour S, Melaku Y, Keus K, Wambugu J, Atkin S, Montgomery J, Ford N, Hook C, Checchi F.
    Trans R Soc Trop Med Hyg; 2005 Jul 21; 99(7):548-54. PubMed ID: 15869770
    [Abstract] [Full Text] [Related]

  • 10. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
    Sowunmi A, Fehintola FA, Adedeji AA, Gbotosho GO, Tambo E, Fateye BA, Happi TC, Oduola AM.
    Trop Med Int Health; 2005 Nov 21; 10(11):1161-70. PubMed ID: 16262741
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of artesunate plus amodiaquine, artesunate plus sulfadoxine-pyrimethamine, and chloroquine plus sulfadoxine-pyrimethamine in patients with uncomplicated Plasmodium falciparum in the Comoros Union.
    Tall A, Rabarijaona LP, Robert V, Bedja SA, Ariey F, Randrianarivelojosia M.
    Acta Trop; 2007 Jun 21; 102(3):176-81. PubMed ID: 17568549
    [Abstract] [Full Text] [Related]

  • 12. Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda.
    Staedke SG, Sendagire H, Lamola S, Kamya MR, Dorsey G, Rosenthal PJ.
    Trop Med Int Health; 2004 May 21; 9(5):624-9. PubMed ID: 15117308
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and effectiveness of the combination of sulfadoxine/pyrimethamine and a 3-day course of artesunate for the treatment of uncomplicated falciparum malaria in a refugee settlement in Zambia.
    Depoortere E, Guthmann JP, Pressé J, Sipilanyambe N, Nkandu E, Balkan S, de Pécoulas PE, Legros D.
    Trop Med Int Health; 2005 Feb 21; 10(2):139-45. PubMed ID: 15679556
    [Abstract] [Full Text] [Related]

  • 14. Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria.
    Talisuna AO, Nalunkuma-Kazibwe A, Langi P, Mutabingwa TK, Watkins WW, Van Marck E, Egwang TG, D'Alessandro U.
    Infect Genet Evol; 2004 Dec 21; 4(4):321-7. PubMed ID: 15374529
    [Abstract] [Full Text] [Related]

  • 15. Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali.
    Djimdé AA, Fofana B, Sagara I, Sidibe B, Toure S, Dembele D, Dama S, Ouologuem D, Dicko A, Doumbo OK.
    Am J Trop Med Hyg; 2008 Mar 21; 78(3):455-61. PubMed ID: 18337343
    [Abstract] [Full Text] [Related]

  • 16. Sulphadoxine/pyrimethamine versus amodiaquine for treating uncomplicated childhood malaria in Gabon: a randomized trial to guide national policy.
    Nsimba B, Guiyedi V, Mabika-Mamfoumbi M, Mourou-Mbina JR, Ngoungou E, Bouyou-Akotet M, Loembet R, Durand R, Le Bras J, Kombila M.
    Malar J; 2008 Feb 12; 7():31. PubMed ID: 18267042
    [Abstract] [Full Text] [Related]

  • 17. Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana.
    Mockenhaupt FP, Teun Bousema J, Eggelte TA, Schreiber J, Ehrhardt S, Wassilew N, Otchwemah RN, Sauerwein RW, Bienzle U.
    Trop Med Int Health; 2005 Sep 12; 10(9):901-8. PubMed ID: 16135198
    [Abstract] [Full Text] [Related]

  • 18. Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
    Marfurt J, Müeller I, Sie A, Maku P, Goroti M, Reeder JC, Beck HP, Genton B.
    Am J Trop Med Hyg; 2007 Nov 12; 77(5):947-54. PubMed ID: 17984359
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of amodiaquine alone and combined with sulfadoxine-pyrimethamine and of sulfadoxine pyrimethamine combined with artesunate.
    Rwagacondo CE, Niyitegeka F, Sarushi J, Karema C, Mugisha V, Dujardin JC, Van Overmeir C, van den Ende J, D'Alessandro U.
    Am J Trop Med Hyg; 2003 Jun 12; 68(6):743-7. PubMed ID: 12887037
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali.
    Tekete M, Djimde AA, Beavogui AH, Maiga H, Sagara I, Fofana B, Ouologuem D, Dama S, Kone A, Dembele D, Wele M, Dicko A, Doumbo OK.
    Malar J; 2009 Feb 26; 8():34. PubMed ID: 19245687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.